GLOBUS MEDICAL INC - A (GMED) Stock Price, Quote, News and Overview
NYSE:GMED - New York Stock Exchange, Inc. - US3795772082 - Common Stock - Currency: USD
GMED Quote, Performance and Key Statistics
GLOBUS MEDICAL INC - A
NYSE:GMED (1/30/2025, 4:15:00 PM)
After market: 93.12 0 (0%)93.12
+0.33 (+0.36%)
The current stock price of GMED is 93.12 USD. In the past month the price increased by 11.05%. In the past year, price increased by 79.03%.
GMED Latest News, Press Releases and Analysis
Why NYSE:GMED is Poised for High Growth.
A fundamental and technical analysis of (NYSE:GMED): Exploring GLOBUS MEDICAL INC - A (NYSE:GMED)'s high growth characteristics.
Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
AUDUBON, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its...
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025
Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74.
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
AUDUBON, Pa., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced...
GMED Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.58 | 223.42B | ||
| ISRG | INTUITIVE SURGICAL INC | 79.15 | 206.65B | ||
| BSX | BOSTON SCIENTIFIC CORP | 43.66 | 151.86B | ||
| SYK | STRYKER CORP | 32.03 | 148.84B | ||
| MDT | MEDTRONIC PLC | 17.52 | 117.96B | ||
| BDX | BECTON DICKINSON AND CO | 18.88 | 72.06B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.42 | 43.19B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 21.22 | 40.91B | ||
| RMD | RESMED INC | 31.08 | 37.82B | ||
| IDXX | IDEXX LABORATORIES INC | 38.72 | 34.72B | ||
| DXCM | DEXCOM INC | 51.54 | 34.22B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 20.93 | 26.36B |
Related stock screener links
About GMED
Company Profile
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 5,000 full-time employees. The company went IPO on 2012-03-08. The firm offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. The company provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. The company includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Company Info
GLOBUS MEDICAL INC - A
2560 General Armistead Ave
Audubon PENNSYLVANIA 19403 US
CEO: David M. Demski
Employees: 5000
Company Website: https://www.globusmedical.com/
Investor Relations: http://www.investors.globusmedical.com
Phone: 16109301800
GMED FAQ
What is the stock price of GMED?
The current stock price of GMED is 93.12 USD.
What is the symbol for GLOBUS MEDICAL INC - A stock?
The exchange symbol of GLOBUS MEDICAL INC - A is GMED and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is GMED stock listed?
GMED stock is listed on the New York Stock Exchange, Inc. exchange.
Is GMED a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for GMED, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of GMED.
Does GMED stock pay dividends?
GMED does not pay a dividend.
When does GMED stock report earnings?
GMED will report earnings on 2025-02-20, after the market close.
What is the Price/Earnings (PE) ratio of GMED?
The PE ratio for GMED is 32.11. This is based on the reported non-GAAP earnings per share of 2.9 and the current share price of 93.12 USD.
What is the Short Interest ratio of GMED stock?
The outstanding short interest for GMED is 1.84% of its float.
GMED Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to GMED. When comparing the yearly performance of all stocks, GMED is one of the better performing stocks in the market, outperforming 92.87% of all stocks.
GMED Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to GMED. GMED has an average financial health and profitability rating.
GMED Financial Highlights
Over the last trailing twelve months GMED reported a non-GAAP Earnings per Share(EPS) of 2.9. The EPS increased by 25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.69% | ||
| ROA | 1.8% | ||
| ROE | 2.25% | ||
| Debt/Equity | 0 |
GMED Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to GMED. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of 30.63% and a revenue growth 60.65% for GMED